Obicetrapib—the Rebirth of CETP Inhibitors?
- Published in:
- Current Atherosclerosis Reports, 2024, v. 26, n. 10, p. 603, doi. 10.1007/s11883-024-01231-5
- By:
- Publication type:
- Article
Works matching IS 15233804 AND DT 2024 AND VI 26 AND IP 10
Results: 4
1
2
Targeting Macrophage Phenotypes and Metabolism as Novel Therapeutic Approaches in Atherosclerosis and Related Cardiovascular Diseases.
- Published in:
- Current Atherosclerosis Reports, 2024, v. 26, n. 10, p. 573, doi. 10.1007/s11883-024-01229-z
- By:
- Publication type:
- Article
3
Therapeutic Monoclonal Antibodies for Metabolic Disorders: Major Advancements and Future Perspectives.
- Published in:
- Current Atherosclerosis Reports, 2024, v. 26, n. 10, p. 549, doi. 10.1007/s11883-024-01228-0
- By:
- Publication type:
- Article
4
PCSK9 and Coronary Artery Plaque—New Opportunity or Red Herring?
- Published in:
- Current Atherosclerosis Reports, 2024, v. 26, n. 10, p. 589, doi. 10.1007/s11883-024-01230-6
- By:
- Publication type:
- Article